In fact, OR51E2 and OR51E1 have been established as prostate specific G-coupled receptor PSGR and PSGR2 among prostate cancer cells and are associated with tumor progression, cancer cell invasiveness and metastasis24. Here, OR51E1 is linked to neoplasm.